Reversible MAO inhibitors in social phobia bulimia, and other disorders.
Liebowitz
M R
MR
College of Physicians and Surgeons Columbia University, New York, NY.
D002032:Bulimia / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D010698:Phobic Disorders / Q000188:drug therapy* / Q000523:psychology
D008996:Monoamine Oxidase Inhibitors